Iovance Biotherapeutics Inc. (0JDK) Forecast & Analyst Ratings

LSE

Currency in USD

13.19

-1.09 (-7.67%)

Real-time Data

07:00 AM

Day's Range

12.92

14.26

52 wk Range

1.76

15.30

Date	Firm	Action	Rating
Sep 17, 2026	Barclays	Maintains	Overweight
Aug 25, 2026	TD Cowen	Maintains	Buy
Aug 20, 2026	UBS	Maintains	Neutral
Aug 18, 2026	Mizuho	Maintains	Outperform
Aug 07, 2026	Barclays	Maintains	Overweight
Aug 07, 2026	Citizens	Maintains	Outperform
May 08, 2026	Chardan Capital	Maintains	Buy
Apr 10, 2026	Chardan Capital	Maintains	Buy
Mar 05, 2026	UBS	Maintains	Neutral
Mar 03, 2026	Citizens	Upgrade	Market Perform → Outperform

Items per row:

1-10 of 30

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

Period	Analysts	Low	Average	High	Year ago
Current quarter	-	-	-	-	-
Next quarter	-	-	-	-	-
Current year	-	-	-	-	-
Next year	-	-	-	-	-

Date	Time	EPS Estimate	EPS Actual	Difference	Surprise PRC
2026-07-14	After Hours	0.09	0.13	+0.04	‪+44.44%‬
2026-04-30	After Hours	2.03	2.68	+0.65	‪+32.02%‬
2025-10-27	After Hours	0.54	0.54	0.00	‪0.00%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated: Oct 6, 2026, 07:00 AM

App Store